Implementation of regulatory best practices enabling $3M+ cost savings
Collaborative development and implementation of BioPhorum regulatory best practices has supported companies in optimizing post-approval change strategies and reducing regulatory burden. By lowering categories of regulatory filings and avoiding unnecessary fees, companies improve efficiency and compliance.
This approach delivers estimated savings of ~$3.1M per post-approval change, alongside accelerated approvals and lifecycle management. A recent example of this is the global implementation of recombinant methods to the LAL pyrogen test.
Shipping validation collaboration delivering $175k–600k annual savings
BioPhorum collaboration to address FDA information requests on shipping validation is enabling the development of risk-based approaches and standardized responses. This reduces the need for unnecessary real-world shipping studies and avoids repetitive work across organizations. Through this work, companies will achieve estimated savings of $175k–600k per year across multiple products, while improving submission quality and timelines.
Regulatory intelligence collaboration enabling $10–15M risk avoidance
BioPhorum Regulatory CMC collaboration is enabling a harmonized approach to global regulatory intelligence, improving submission readiness and avoiding misalignment with health authorities.
Through shared insights and proactive planning, companies are reducing delays and compliance risks.
This work is delivering an estimated value of $10–15M per year and per organization, by avoiding supply chain disruption and more efficient regulatory strategies.